These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29958300)

  • 1. Development and testing of AAV-delivered single-chain variable fragments for the treatment of methamphetamine abuse.
    Hay CE; Gonzalez GA; Ewing LE; Reichard EE; Hambuchen MD; Nanaware-Kharade N; Alam S; Bolden CT; Owens SM; Margaritis P; Peterson EC
    PLoS One; 2018; 13(6):e0200060. PubMed ID: 29958300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Development and Characterization of an scFv-Fc Fusion-Based Gene Therapy to Reduce the Psychostimulant Effects of Methamphetamine Abuse.
    Hay CE; Ewing LE; Hambuchen MD; Zintner SM; Small JC; Bolden CT; Fantegrossi WE; Margaritis P; Owens SM; Peterson EC
    J Pharmacol Exp Ther; 2020 Jul; 374(1):16-23. PubMed ID: 32245884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Adeno-Associated Virus-Mediated Expression of Methamphetamine Antibody Attenuates Methamphetamine-Induced Hyperactivity in Mice.
    Chen YH; Wu KJ; Wu KL; Wu KL; Tsai HM; Chen ML; Chen YW; Hsieh W; Lin CM; Wang Y
    Sci Rep; 2017 Apr; 7():46301. PubMed ID: 28387350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Customizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applications.
    Peterson EC; Gentry WB; Owens SM
    Adv Pharmacol; 2014; 69():107-27. PubMed ID: 24484976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering.
    Thakkar S; Nanaware-Kharade N; Celikel R; Peterson EC; Varughese KI
    Sci Rep; 2014 Jan; 4():3673. PubMed ID: 24419156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin-1 downregulation in the nucleus accumbens promotes methamphetamine-primed reinstatement in mice.
    Huang M; Yan C; Yang X; Zhou X; Lv W; Guo N; Li Y; Bai J
    Neuropharmacology; 2018 Sep; 139():117-123. PubMed ID: 29981334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of microRNA-29c in the nucleus accumbens modulates methamphetamine -induced locomotor sensitization in mice.
    Su H; Zhu L; Li J; Wang R; Liu D; Han W; Cadet JL; Chen T
    Neuropharmacology; 2019 Apr; 148():160-168. PubMed ID: 30639389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA changes in nucleus accumbens related to methamphetamine addiction in mice.
    Zhu L; Li J; Dong N; Guan F; Liu Y; Ma D; Goh EL; Chen T
    Sci Rep; 2016 Nov; 6():36993. PubMed ID: 27869204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylation of a High-Affinity Anti-(+)Methamphetamine Single Chain Antibody Fragment Extends Functional Half-Life by Reducing Clearance.
    Reichard EE; Nanaware-Kharade N; Gonzalez GA; Thakkar S; Owens SM; Peterson EC
    Pharm Res; 2016 Dec; 33(12):2954-2966. PubMed ID: 27620175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Characterization of AAV-Expressed Recombinant Anti-VEGF Single-Chain Variable Fragments In Vitro.
    Wimmer T; Lorenz B; Stieger K
    J Ocul Pharmacol Ther; 2015 Jun; 31(5):269-76. PubMed ID: 25867736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrastriatal gene delivery of GDNF persistently attenuates methamphetamine self-administration and relapse in mice.
    Yan Y; Miyamoto Y; Nitta A; Muramatsu S; Ozawa K; Yamada K; Nabeshima T
    Int J Neuropsychopharmacol; 2013 Aug; 16(7):1559-67. PubMed ID: 23432945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using hapten design to discover therapeutic monoclonal antibodies for treating methamphetamine abuse.
    Peterson EC; Gunnell M; Che Y; Goforth RL; Carroll FI; Henry R; Liu H; Owens SM
    J Pharmacol Exp Ther; 2007 Jul; 322(1):30-9. PubMed ID: 17452421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine development against methamphetamine drug addiction.
    Hossain MK; Hassanzadeganroudsari M; Nurgali K; Apostolopoulos V
    Expert Rev Vaccines; 2020 Dec; 19(12):1105-1114. PubMed ID: 33251859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression signature of methamphetamine use and addiction in the rat nucleus accumbens.
    Sim MS; Soga T; Pandy V; Wu YS; Parhar IS; Mohamed Z
    Metab Brain Dis; 2017 Dec; 32(6):1767-1783. PubMed ID: 28681200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and preclinical testing of a high-affinity single-chain antibody against (+)-methamphetamine.
    Peterson EC; Laurenzana EM; Atchley WT; Hendrickson HP; Owens SM
    J Pharmacol Exp Ther; 2008 Apr; 325(1):124-33. PubMed ID: 18192498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico experiments of single-chain antibody fragment against drugs of abuse.
    Hu G; Chen LY
    Biophys Chem; 2010 Dec; 153(1):97-103. PubMed ID: 21056529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods in drug abuse models: comparison of different models of methamphetamine paradigms.
    Kobeissy FH; Mitzelfelt JD; Fishman I; Morgan D; Gaskins R; Zhang Z; Gold MS; Wang KK
    Methods Mol Biol; 2012; 829():269-78. PubMed ID: 22231820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of complement factor H and imaging of small molecules by MALDI-MSI in a methamphetamine behavioral sensitization model.
    Xu J; Zhang Z; Liu R; Sun Y; Liu H; Nie Z; Zhao X; Pu X
    Behav Brain Res; 2019 May; 364():233-244. PubMed ID: 30731099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine alters microglial immune function through P2X7R signaling.
    Fernandes NC; Sriram U; Gofman L; Cenna JM; Ramirez SH; Potula R
    J Neuroinflammation; 2016 Apr; 13(1):91. PubMed ID: 27117066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy.
    Zuber C; Mitteregger G; Schuhmann N; Rey C; Knackmuss S; Rupprecht W; Reusch U; Pace C; Little M; Kretzschmar HA; Hallek M; Büning H; Weiss S
    J Gen Virol; 2008 Aug; 89(Pt 8):2055-2061. PubMed ID: 18632978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.